Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Vera Therapeutics has raised $261.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Vera Therapeutics's investors include Kleiner Perkins, Abingworth, Sofinnova Investments, Oxford Finance LLC, Fidelity.
Vera Therapeutics is headquartered in South San Francisco, United States.
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Vera Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vera Therapeutics — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/vera-therapeutics. Accessed September 4, 2026.
VCBacked. (2025). Vera Therapeutics — Funding & Investors. Retrieved September 4, 2026, from https://www.vcbacked.co/company/vera-therapeutics
{{cite web |title=Vera Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vera-therapeutics |website=VCBacked |access-date=September 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated